<http://schema.org/description>
"Shares of Oncothyreon Inc. (ONTY) slumped significantly after collaboration partner Germany-based Merck KGaA (MKGAY) informed the former that a phase I/II study, on tecemotide, did not meet its primary endpoint."^^<http://www.w3.org/2001/XMLSchema#string>
<https://www.zacks.com/stock/news/144520/oncothyreon-onty-slumps-tecemotide-fails-phase-iii-study>